Behavioural characteristics and gene expression in the hyperactive wiggling (Wig) rat

Eur J Neurosci. 2007 Jun;25(12):3659-66. doi: 10.1111/j.1460-9568.2007.05613.x.

Abstract

Recently, congenic wiggling (Wig) rats were described as a good model for attention-deficit hyperactivity disorder; 12- to 14-week-old animals demonstrated hyperactivity, impulsive behaviour and an impaired working memory. Here, we show that 4- to 5-week-old Wig rats displayed significantly greater spontaneous motor activity than control rats during a period of darkness. Subcutaneous injection of 4 mg/kg methamphetamine exacerbated hyperactivity, the reverse of its effect in rats with neonatally induced 6-hydroxydopamine lesions. Immunohistochemistry showed low levels of tyrosine hydroxylase in the ventral midbrain, similar to 6-hydroxydopamine-treated rats. In cDNA macroarrays, 4-week-old Wig rats showed increased expression of the adenosine A2a receptor in the dorsal striatum, macrophage migration inhibitory factor in the frontal cortex, ventral striatum and midbrain, and calbindin 2 in the dorsal and ventral midbrain. Expression of the gamma-aminobutyric acid (GABA) transporter and sterol carrier protein 2 genes was reduced in all regions. Dopamine transporter gene expression was increased in the dorsal midbrain but decreased in the ventral midbrain, a pattern distinct from that induced by 6-hydroxydopamine. Although abnormal development of dopaminergic neurons may underlie motor hyperactivity, other mechanisms may control responsiveness to methamphetamine. Wig rats may provide a model of attention-deficit hyperactivity disorder in which treatment with psychostimulants accelerate the hyperactivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Agents / pharmacology
  • Analysis of Variance
  • Animals
  • Animals, Congenic
  • Animals, Newborn
  • Behavior, Animal / drug effects
  • Behavior, Animal / physiology*
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Central Nervous System Stimulants / pharmacology
  • Circadian Rhythm / drug effects
  • Circadian Rhythm / physiology
  • GABA Plasma Membrane Transport Proteins / genetics
  • GABA Plasma Membrane Transport Proteins / metabolism
  • Gene Expression / drug effects
  • Gene Expression / physiology*
  • Gene Expression Profiling / methods
  • Hyperkinesis / metabolism*
  • Hyperkinesis / physiopathology*
  • Mesencephalon / metabolism
  • Methamphetamine / pharmacology
  • Oligonucleotide Array Sequence Analysis / methods
  • Oxidopamine / pharmacology
  • Rats
  • Receptor, Adenosine A2A / genetics
  • Receptor, Adenosine A2A / metabolism
  • Time Factors
  • Tyrosine 3-Monooxygenase / metabolism
  • gamma-Aminobutyric Acid

Substances

  • Adrenergic Agents
  • Carrier Proteins
  • Central Nervous System Stimulants
  • GABA Plasma Membrane Transport Proteins
  • Receptor, Adenosine A2A
  • sterol carrier proteins
  • Methamphetamine
  • gamma-Aminobutyric Acid
  • Oxidopamine
  • Tyrosine 3-Monooxygenase